ABSTRACT Systemic side-effects during irrigation of body cavities with the antiseptic noxythiolin (Noxyflex) have not previously been reported. In two patients undergoing intrapleural lavage with 1% noxythiolin, anorexia and nausea with or without vomiting were observed which suggested systemic absorption. This was confirmed by chemical assays of serum from these patients. The process of absorption was studied in rabbits by injection of noxythiolin into the pleural or peritoneal cavity. Serum levels reached a peak at one to two hours indicating rapid entry into the bloodstream, declined slowly over seven hours, and reached zero before 24 hours. Although side-effects resulted from systemic absorption of noxythiolin during irrigation of the pleural cavity, they were mild and did not contraindicate the use ofnoxythiolin as an irrigant. Awareness ofthe mechanism of side-effects ofnoxythiolin provides a rational basis for management of symptoms through reduction of the volume or frequency of irrigation.
The widespread use of antibiotics in recent years has resulted in a rising incidence of antibiotic resistance in bacteria.' As a result there is an increasing role for antiseptics in treating infections in body cavities or on the skin. The instillation ofantibacterial drugs into the pleural cavity is an accepted and effective form of therapy for intrapleural infection especially after pneumonectomy. Clagett recommended intrapleural neomycin in his procedure for the management of post-pneumonectomy empyema because of its broad anti-bacterial spectrum.2 However Meakins and Allard recently reported neomycin toxicity following Clagett's procedure. They urged caution in the intrapleural use of neomycin and advised routine monitoring of serum levels. 3 Noxythiolin (Noxyflex) is an antiseptic of low toxicity which is frequently instilled into the bladder or peritoneal cavity.4 5 Systemic side-effects have not previously been reported. In the preceding article6 we report the use of intrapleural noxythiolin in three patients to control infection. In two of these patients we observed anorexia, nausea, and vomiting as possible side-effects. This suggested systemic absorption of noxythiolin from the pleural cavity.
An assay was therefore used to monitor serum levels of noxythiolin in patients in whom side-effects were observed. In a study in rabbits, the absorption of noxythiolin from the pleural cavity was 24 hours. Two months later the rabbits were killed and the pleural cavities examined. Intraperitoneal: in this method two rabbits were given intraperitoneal noxythiolin 28 5 mg/kg. Hourly blood samples were taken for four hours. Two months later these rabbits were killed and the peritoneal cavities examined.
Cardiovascular effects
In two rabbits anaesthetised with urethane (1 *25 g/kg), arterial blood pressure, heart rate, and respiratory rate were recorded while 1 % noxythiolin in normal saline was given as an intravenous infusion at a rate of 1 mg/kg per minute.
Noxythiolin assay An assay for organic sulphur compounds such as the thioureas was originally described by Grote.7 Grote's specific reagent can be used with slight modification for the assay of noxythiolin. The assay does not distinguish between noxythiolin and its breakdown product methylthiourea. We have scaled down the assay for use with I ml samples of serum. To 1 ml of serum, 0 5 ml of sodium tungstate solution (10% anhydrous by weight) and 0 5 ml of 05 molar H2SO4 were added, and the mixture was centrifuged. To 0-6 ml of the supernatant, 0 4 ml of 14% fresh Na2HPO4.2H20 and 0-1 ml of diluted Grote's reagent (1 in 5) were added. The OD61onm was measured after one hour. A simultaneous standard was prepared using noxythiolin dissolved in serum and the serum levels calculated from the standard curve. Grote's reagent was made by dissolving 0-5 g sodium nitroprusside in 10 ml water, and adding 0 5 g hydroxylamine hydrochloride and 1 g NaHCOa mixed together. When the evolution of gas had ceased, 0-1 ml bromine was added, the mixture diluted to 25 ml with water, and allowed to stand at room temperature for five to 10 hours before being stored at 40C. This solution was diluted 1 in 5 for assay. The assay was sensitive enough to detect concentrations of noxythiolin as low as 5 ,tg/ml.
A partitioning test in whole blood showed that noxythiolin was equally distributed between red cells and serum. No evidence of binding to plasma protein was found.
Results

PATIENTS' RESPONSES AND ASSAY RESULTS
Patient 1 received 42 mg/kg of noxythiolin 12-hourly intrapleurally and a serum level of 48 ,g/ml was reached. She complained of malaise, anorexia, nausea, and vomiting. Irrigation was stopped for 24 hours in the middle of the course of treatment. The nausea and vomiting disappeared during this period only to reappear when irrigation was started. She felt well again when the nine-day course of irrigation was completed. Her empyema was sterilised and she suffered no permanent ill effects from the therapy.
Patient 2 received 25 mg/kg of intrapleural noxythiolin four hourly and her serum level reached 62 ,ug/ml. She complained of malaise, anorexia, and nausea during the five-day period of irrigation with noxythiolin. These symptoms disappeared when the course of irrigation was completed.
The other two patients who received a continuous infusion of 1 % noxythiolin into the pericardial cavity or into the site of an infected fractured femur had serum levels of 11 sug/ml and 8 ,g/ml respectively.
Neither of these patients showed any side-effects. These results are summarised in the table.
RABBIT STUDIES Absorption Figure 1 shows examples of the rise and fall of serum levels after the injection of 28 5 mg/kg of noxythiolin into the pleural cavity in three rabbits and into the peritoneal cavity in two rabbits. Serum concentration FL Rosenfeldt, J R Glover, and D Marossy reached a peak in one to tw linear fashion over the sevei Figure 2 shows the mean c groups of intrapleural noxy was seen at all dose levels. P at three to four hours in gr hours in groups 2 Louis and Benedetti measured blood radioactivity in the rat after the intraperitoneal administration of labelled noxythiolin and showed rapid absorption and peak activity at 30 to 60 minutes.9 As in the present study it was not possible to distinguish between noxythiolin and its breakdown products in the serum. The results of our limited studies of the intraperitoneal absorption of noxythiolin were similar to the intrapleural studies. As would be expected there was a relationship between the peak serum level of noxythiolin and the volume of 1 % noxythiolin introduced into the pleural cavity. The dosage in group 1, 57 mg/kg, was nearest to the clinical regimen and produced the same peak serum level as that measured in patient 2, who had side-effects. Halving the dosage (group 2) led to a three-fold reduction in peak serum levels.
How should these results influence the practical management of intrapleural irrigation with noxythiolin or other potentially toxic substances? Great reductions in the volume of irrigant solution are undesirable because much of the beneficial effect of irrigation is caused by the physical action of the fluid in washing out infected material. Reducing the concentration of noxythiolin below 1 % is also undesirable as this impairs its antibacterial effect. One solution to the problem which we have used is to begin with four-hourly irrigations of 100-200 ml of 1 % noxythiolin and after 12-24 hours to alternate these with one or more four-hourly cycles of normal saline.
We conclude that while side-effects can result from systemic absorption of noxythiolin during irrigation of the pleural or peritoneal cavities, systemic absorp- 
